149 filings
Page 2 of 8
8-K
ojewij
1 Nov 23
Revolution Medicines Also Announces the Final Exchange Ratio of 0.1112
7:08am
425
s8kn5vzqgqbqs1fn
23 Oct 23
Business combination disclosure
6:13am
8-K
r9hgnmw
23 Oct 23
Regulation FD Disclosure
6:11am
8-K
ogdno
13 Oct 23
Other Events
11:54am
EFFECT
ulagk
2 Oct 23
Notice of effectiveness
12:15am
DEFM14A
07b5wcb7rvb
29 Sep 23
Proxy related to merger
4:19pm
424B3
5yk7fpt88ijpkacie8tx
29 Sep 23
Prospectus supplement
4:17pm
S-4/A
o8l5mxd
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm
CORRESP
5tz0n99d
27 Sep 23
Correspondence with SEC
12:00am
UPLOAD
cb4bwx
20 Sep 23
Letter from SEC
12:00am
S-4
4xxqh8
13 Sep 23
Registration of securities issued in business combination transactions
5:20pm
8-K
lerg4f4a
5 Sep 23
Departure of Directors or Certain Officers
4:02pm
8-K
3wvpdn9z
8 Aug 23
Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress
4:04pm
425
tmm5r8zgo
1 Aug 23
Business combination disclosure
5:24pm
425
uu10uca pxzztunzn5h
1 Aug 23
Business combination disclosure
5:22pm
425
o7i5nnph
1 Aug 23
Business combination disclosure
5:16pm
425
qtfmsftin5n8g4002f
1 Aug 23
Business combination disclosure
5:13pm
425
2daae04tjhdir
1 Aug 23
Business combination disclosure
5:11pm
425
6jrin gru
1 Aug 23
Business combination disclosure
5:09pm